Taysha Gene Therapies, Inc. number of employees

Taysha Gene Therapies, Inc. reported 99 employees at December 31, 2025 in its latest annual report. Revenue per employee was $98,717.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	99	—	$98,717	10-K, filed March 19, 2026

What the annual reports say

The principal purposes of our equity incentive plans are to attract, retain and motivate selected employees, consultants and directors through the granting of stock-based compensation awards. 26 As of December 31, 2025, we had 99 employees, all of whom were full-time. 2025 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: CGON vs TSHA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Taysha Gene Therapies, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Taysha Gene Therapies, Inc.